Real-time enrollment status for this macular edema clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:50 PM UTC
| NCT Number | NCT06996080 |
| Recruiting Status | Recruiting |
| Condition | Macular Edema |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 55 sites in the US |
| Sponsor | Kodiak Sciences Inc |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of October 15, 2026: Clinical trial NCT06996080 is currently recruiting participants. This phase3 study for macular edema is actively seeking new participants at 55 locations across the United States. The study is sponsored by Kodiak Sciences Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06996080 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 55 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06996080 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.